Navigation Links
Massive microRNA scan uncovers leads to treating muscle degeneration
Date:10/17/2007

Researchers have discovered the first microRNAs tiny bits of code that regulate gene activity linked to each of 10 major degenerative muscular disorders, opening doors to new treatments and a better biological understanding of these debilitating, poorly understood, often untreatable diseases. The study, to be published online this week by the Proceedings of the National Academy of Sciences, was led by Iris Eisenberg, PhD, of the Program in Genomics at Childrens Hospital Boston. Louis Kunkel, PhD, director of the Program in Genomics and an investigator with the Howard Hughes Medical Institute, was senior investigator.

The disorders include the muscular dystrophies (Duchenne muscular dystrophy, Becker muscular dystrophy, limb girdle muscular dystrophies, Miyoshi myopathy, and fascioscapulohumeral muscular dystrophy); the congenital myopathies (nemaline myopathy); and the inflammatory myopathies (polymyositis, dermatomyositis, and inclusion body myositis). While past studies have linked them with an increasing number of genes, it's still largely unknown how these genes cause muscle weakness and wasting, and, more importantly, how to translate the discoveries into treatments.

For instance, most muscular dystrophies begin with a known mutation in a master gene, leading to damaged or absent proteins in muscle cells. In Duchenne and Becker muscular dystrophies, the absent protein is dystrophin, as Kunkel himself discovered in 1987. Its absence causes muscle tissue to weaken and rupture, and the tissue becomes progressively nonfunctional through inflammatory attacks and other damaging events that arent fully understood.

The initial mutations do not explain why patients are losing their muscle so fast, says Eisenberg. There are still many unknown genes involved in these processes, as well as in the inflammatory processes taking place in the damaged muscle tissue.

She and Kunkel believe microRNAs may help provide the missing
'/>"/>

Contact: James Newton
james.newton@childrens.harvard.edu
617-919-3110
Children's Hospital Boston
Source:Eurekalert

Page: 1 2

Related biology news :

1. New plant DNA libraries provides massive boost to worlds plant researchers
2. Underlying cause of massive pinyon pine die-off revealed
3. Massive duplication of genes may solve Darwins abominable mystery about flowering plants
4. PNAS study reveals why organs fail following massive trauma
5. Massive coral death attributed to earthquake
6. Massive herds of animals found to still exist in Southern Sudan
7. Yale Scientists Find MicroRNA Regulates Ras Cancer Gene
8. Cooperation is key—a new way of looking at MicroRNA and how it controls gene expression
9. NYU, Rockefeller researchers find complexity of regulation by microRNA genes
10. MicroRNAs play a big part in gene regulation - and evolution
11. Molecular steps involved in the creation of gene-silencing microRNAs identified

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...O, Calif., Nov. 9 Genencor, a divi... Energy Award" from the American Institute of Chem...amily of enzymes for cellulosic ethanol. Yesterday...e, presented the award to Landon Steele, who is Ma...#174; Product Manager, and Aaron Kelley, who is Se...
(Date:11/9/2009)... culprit responsible for the rapid, mysterious dea...s been found by collaborating scientists at Rutger...itution (WHOI). This same chemical may hold unexp...covered a previously unknown lipid, or fatty compo...g Emiliania huxleyi , a phytoplankton that plays ...
(Date:11/9/2009)..., NOVEMBER 9, 2009 A nutritionist whose research...to the federal Women, Infants and Children (WIC) f...Higgins Award for outstanding achievement in the f...son, Ph.D., MNS, , a professor in the Department o...alifornia, Los Angeles School of Public Health, wi...
Breaking Biology News(10 mins):Genencor Wins The American Institute of Chemical Engineers (AIChE) Sustainable Energy Award For Accellerase(R) Cellulosic Ethanol Enzymes 2Newly discovered fat molecule: An undersea killer with an upside 2Newly discovered fat molecule: An undersea killer with an upside 3Newly discovered fat molecule: An undersea killer with an upside 4March of Dimes honors Dr. Gail Harrison for outstanding work in maternal-fetal nutrition 2SEI Defined Benefit Client Recognized With Leading Plan Design Award 5454 1SEI Defined Benefit Client Recognized With Leading Plan Design Award 5454 2DuraHeart 26amp 3B 238482 3B Third Generation Left Ventricular Assist System Featured at 23rd Annual Meeting of the European Association for Cardio th 59434 1DuraHeart 26amp 3B 238482 3B Third Generation Left Ventricular Assist System Featured at 23rd Annual Meeting of the European Association for Cardio th 59434 2DuraHeart 26amp 3B 238482 3B Third Generation Left Ventricular Assist System Featured at 23rd Annual Meeting of the European Association for Cardio th 59434 3Dr Floyd Bloom Joins aTyr Pharmas Scientific Advisory Board 14466 1Dr Floyd Bloom Joins aTyr Pharmas Scientific Advisory Board 14466 2Dr Floyd Bloom Joins aTyr Pharmas Scientific Advisory Board 14466 3
...he primary targets of HIV-1 infection in the human... study published in the February 2007 issue of the...ndings are likely to guide development of new stra...he majority of HIV-1 infected individuals worldwid...xual contact," explain study authors Dr. Florian H...
...n his Jan. 23 State of the Union address, Presiden...on,s dependency on foreign oil by requiring the pr... and alternative fuels by 2017, roughly five times... gallons by 2012. , Among the most promising alter.... Currently, the main biofuel used in the United S...
...n his Jan. 23 State of the Union address, Presiden...on,s dependency on foreign oil by requiring the pr... and alternative fuels by 2017, roughly five times... gallons by 2012. , Among the most promising alter.... Currently, the main biofuel used in the United S...
Other Biology News:Researchers discover new details about HIV-1 entry and infection 2Custom-made cancer cell attacks 2Custom-made cancer cell attacks 3Cellulosic ethanol: Fuel of the future? 2Cellulosic ethanol: Fuel of the future? 3
(Date:11/6/2009)...wire-FirstCall/ - Microbix Biosystems Inc. (the "C...Form 52-109F1 Certification of Annual Filings of W...es Long, the Chief Financial Officer (the "Officer...tion with the annual audited financial statements ...ompany initially filed the annual financial statem...
(Date:11/6/2009)... Helix BioPharma Corp. (...ced that John Docherty, president and chief operat...s 6th annual Investor Summit on November 10, 2009 ... Mr. Docherty will provide an overview of the Comp... and Topical Interferon Alpha-2b. The slide show ...
(Date:11/6/2009)...vember 6 EUCODIS Bioscience, a com...arketing enzymes for the,chemical industry announc...ment with Bio Sidus, the leading biopharmaceutical...t gives EUCODIS Bioscience exclusive access - for ...proprietary collection of,psychrophilic bacteria s...
(Date:11/6/2009)...Nov. 6 Calbiotech, Inc. announced ...novative Research (SBIR) Phase I contract by the U...der terms of the agreement, Calbiotech will develo...is of Dengue virus. ,, Dengue virus is a mos...at to military forces deployed to tropical areas o...
Breaking Biology Technology:Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 3EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus 2Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 2
...d., March 16 Micromet, Inc. (Nasdaq: MITI ), a ...etary antibodies for the treatment of cancer, infl...the publication of six abstracts for poster presen... place from April 20-24, 2009, in Denver, Colorado... , , , Lutterbuese, R. et al. (2009). H...
...ch 16 PAREXEL experts will address the benefits o... 110th Annual Meeting of the American Society for ... be held at the Gaylord National Resort in Nationa...ocus of PAREXEL,s presence at the ASCPT meeting wi...nd best practice approaches for identifying and se...
...ng expenses decreased by 33% in 2008; Forecast cut...n 2009 , , CTI expects to complete pixantrone ND...ell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC...ial results for the fourth quarter and year ended ... Met primary endpoint in the Phase III study ...
Other Biology Technology:Micromet to Present Six Posters on Progress of BiTE Antibodies at the Annual Meeting of American Association for Cancer Research 2Micromet to Present Six Posters on Progress of BiTE Antibodies at the Annual Meeting of American Association for Cancer Research 3Micromet to Present Six Posters on Progress of BiTE Antibodies at the Annual Meeting of American Association for Cancer Research 4Micromet to Present Six Posters on Progress of BiTE Antibodies at the Annual Meeting of American Association for Cancer Research 5PAREXEL Experts to Address Benefits of Rigorous Early Phase Development at Annual ASCPT Meeting 2PAREXEL Experts to Address Benefits of Rigorous Early Phase Development at Annual ASCPT Meeting 3PAREXEL Experts to Address Benefits of Rigorous Early Phase Development at Annual ASCPT Meeting 4Cell Therapeutics, Inc. (CTI) Reports 2008 Fourth Quarter and Year End Financial Results 2Cell Therapeutics, Inc. (CTI) Reports 2008 Fourth Quarter and Year End Financial Results 3Cell Therapeutics, Inc. (CTI) Reports 2008 Fourth Quarter and Year End Financial Results 4Cell Therapeutics, Inc. (CTI) Reports 2008 Fourth Quarter and Year End Financial Results 5Cell Therapeutics, Inc. (CTI) Reports 2008 Fourth Quarter and Year End Financial Results 6Cell Therapeutics, Inc. (CTI) Reports 2008 Fourth Quarter and Year End Financial Results 7Cell Therapeutics, Inc. (CTI) Reports 2008 Fourth Quarter and Year End Financial Results 8
Mouse Anti-Human FACTOR I Monoclonal Antibody, Unconjugated, Clone 3R2/2 from AbD Serotec
Human, Bovine, Porcine, Rat VIP, aa 6-28 from Biotrend Chemikalien GmbH
RAPTOR from Bioinformatics Solutions Inc.
Mouse Anti-L1 Protein of Human Papilloma Virus Monoclonal Antibody, Unconjugated, Clone CAMVIR-1 from BD Biosciences Pharmingen
Biology Products: